Care Delivery

Medical mistakes are one of the leading causes of death in the U.S., and patients can experience harm when they are seeking care at hospitals. Knowing how patients are being harmed is crucial for healthcare providers to improve quality of care and outcomes.

Customs and Border Protection will not administer flu vaccines to migrants held in border detention facilities, CBS News reported. The decision comes just weeks before the flu season in the U.S. is expected to hit.

Signify Health and Remedy Partners, two portfolio companies of private equity firm New Mountain Capital, have signed an agreement to merge.

U.S. healthcare spending far outpaces other high-income countries, but social spending is not far off, just slightly below average, according to a new study published in Health Affairs.

Two institutional-based health plans in New England have announced their plans to merge.

Unionized workers from one of the nation’s largest health systems have voted to strike against the healthcare organization in early October amid ongoing labor negotiations.

 

Drugmakers, wanting to develop new products informed by disease insights, are snapping up genetic profiles of hospital patients and spending hundreds of millions of dollars to get the data. But the practice is throwing into question who should control this “valuable genetic data."

Enrollment of people who are ineligible for subsidies on the individual healthcare market appears to be slowing down, according to a recent report from CMS.

Hospital prices continue to rise and are a major contributor to overall spending in the healthcare sector, which is expected to hit $6 trillion by 2027.

Out-of-network billing in emergency departments has risen over the last few years, often leaving patients with surprise expenses even when they have insurance coverage and receive care from an in-network hospital.

HHS has awarded $400 million through the Health Resources and Services Administration (HRSA) to fund community health centers, rural organizations and academic institutions to develop and expand services to combat the opioid abuse crisis.

CMS has decided to cover an expensive and new therapy that uses a patient’s own genetically modified immune cells to treat cancer.